Diane Weiser | Senior Vice President of Corporate Communications & Investor Relations |
Robert Blum | President & Chief Executive Officer |
Fady Malik | Executive Vice President, Research & Development |
Steve Heitner | VP:Clinical Research & Therapeutic Area Lead at Cytokinetics Inc. |
Andrew Callos | Executive Vice President & Chief Commercial Officer |
Robert Wong | Vice President & Chief Accounting Officer |
Ching Jaw | Senior Vice President & Chief Financial Officer |
Jason Butler | JMP |
Jason Zemansky | BofA. |
Joe Pantginis | H.C. Wainwright |
Yasmeen Rahimi | Piper Sandler |
Salim Syed | Mizuho |
Justin Kim | Oppenheimer |
Srikripa Devarakonda | Truist Securities |
Good afternoon, and welcome, ladies and gentlemen, to Cytokinetics Second Quarter 2020 Conference Call. [Operator Instructions] I'll now turn the call over to Diane Weiser, Cytokinetics Senior Vice President of Corporate Communications and Investor Relations. Please go ahead.
Good afternoon, and thanks for joining us on the call today. Robert Blum, President and Chief Executive Officer, will begin with an overview of the quarter and recent developments.